Derivation of biomonitoring equivalents (BE values) for bismuth
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier BV in Regulatory Toxicology and Pharmacology
- Vol. 114, 104672
- https://doi.org/10.1016/j.yrtph.2020.104672
Abstract
No abstract availableKeywords
Funding Information
- Health Canada (4500323309)
- Health Canada (4500323309)
This publication has 19 references indexed in Scilit:
- Human biomonitoring assessment values: Approaches and data requirementsInternational Journal of Hygiene and Environmental Health, 2011
- Guidelines for the derivation of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert WorkshopRegulatory Toxicology and Pharmacology, 2008
- Biomonitoring equivalents: A screening approach for interpreting biomonitoring results from a public health risk perspectiveRegulatory Toxicology and Pharmacology, 2007
- Analytical techniques for the determination of bismuth in solid environmental samplesTrAC Trends in Analytical Chemistry, 2006
- Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrateBritish Journal of Clinical Pharmacology, 1996
- Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrateBritish Journal of Clinical Pharmacology, 1996
- safety of bismuth in the treatment of gastrointestinal diseasesAlimentary Pharmacology & Therapeutics, 1996
- Safety and Pharmacokinetics: Colloidal Bismuth SubcitrateScandinavian Journal of Gastroenterology, 1991
- BISMUTH TOXICITY—A REASSESSMENTJournal of Clinical Pharmacy & Therapeutics, 1989
- Absence of carcinogenic activity in BD rats after oral administration of high doses of bismuth oxychlorideFood and Cosmetics Toxicology, 1975